Private Equity
Bioniche Pharma, an injectable drugmaker owned by Roundtable Healthcare Partners, has acquired Duraclon (clonidine hydrochloride injection) and Methadone Hydrochloride Injection USP from Xanodyne Pharmaceuticals Inc. No financial terms were disclosed. Xanodyne has raised over $230 million in VC funding, from firms like AIG Investments, Aisling Capital, Blue Chip Venture Co., Essex Woodlands Health Ventures, HealthCare Ventures, MPM Capital and Union Springs.
2 min read · 16 November 2009
Sezmi, a Belmont, Calif.-based developer of a set-top box that combines traditional television content with on-demand movies and Internet video, has raised $25 million in third-round funding. An unnamed strategic investors was joined by return backers Morgenthaler Partners, Index Ventures, Legend Ventures, Omni Capital and TD Fund. The company previously raised around $53 million, including a $33 million infusion last year at a post-money valuation of approximately $170 million.
2 min read · 16 November 2009
Fate Therapeutics, a La Jolla, Calif.-based stem cell biotech company focused on cell fate control, has raised $30 million in Series B funding. OVP Venture Partners led the round, and was joined by fellow return backers ARCH Venture Partners, Polaris Venture Partners and Venrock. The company previously raised $12 million.
4 min read · 16 November 2009
Zenph Sound Innovations, a Raleigh, N.C.-based developer of "software and algorithms to transform music into data in order to understand and re-perform music in novel ways," has raised $10.7 million in new VC funding. Intersouth Partners led the round, and was joined by Capitol Broadcasting Company.
4 min read · 13 November 2009
Arrowsight Inc., a Mt. Kisco, N.Y.-based provider of third-party remote video auditing technology and services, has raised $6.75 million in new VC funding led by Oak Street Investments.
2 min read · 13 November 2009
1 min read · 12 November 2009
1 min read · 12 November 2009
Abbott Labs has agreed to acquire the global rights to an antibody to nerve growth factor from PanGenetics BV, a Dutch antibody developer. The deal includes a $170 million up-front payment and up to $20 million in additional earn-outs. PanGenetics has raised VC funding from Edmond de Rothschild Investment Partners, Biogen Idec New Ventures, Fortis Private Equity, Index Ventures, Forbion Capital Partners and Credit Agricole Private Equity.
2 min read · 12 November 2009
Redfin Corp., a Seattle-based online real estate broker, has raised $10 million in Series D funding. Greylock Partners led the round, and was joined by return backers Madrona Venture Group, Draper Fisher Jurvetson, Vulcan Capital and The Hillman Company. Redfin has now raised $30.8 million in total VC funding since its 2002 inception.
3 min read · 12 November 2009
Caring.com, a San Mateo, Calif.-based provider of eldercare and end-of-life content, has raised $10 million in Series B funding. Shasta Ventures led the round, and was joined by return backers DCM and Split Rock Partners. Caring.com previously raised $6 million.
3 min read · 12 November 2009
